Skip to content
Home/Companies/Biotech/Centogene
CE

Centogene

Biotech·Germany·Exited 2019·Held 2yr

Centogene is a biotech company, headquartered in Germany.

Entry
2017
Hold
2yr
Exit
2019
Est. EV
–

Who owns Centogene?

Centogene was owned by DPE Deutsche Private Equity through DPE Fund III (2017 vintage) from 2017 to 2019, exited via IPO.

Hand-verified · updated 2026-07-03

DPE Deutsche Private Equity
Investor
DPE Deutsche Private Equity
DPE Fund III · 2017 · Buyout

Key facts

HQGermany
SectorBiotech
StatusAcquired
Exit Type
IPO
Buyer
–
MOIC
–
Exit Year
2019

More from DPE Fund III

Other portfolio companies in the same fund.

Ortheum
Active
HealthcareGermany· 2022
BplusL
Active
Business ServicesGermany· 2020
Mehler Vario Systems
Active
Aerospace & DefenceGermany· 2020
DEUBIS Group
Exited 2024
ConstructionGermany· 2019
valantic
Exited 2022
IT ServicesGermany· 2019
to
Air Alliance Group
Active
Business ServicesGermany· 2018

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings